BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jan 25, 2017
Clinical News

Vemlidy regulatory update

Read More
BioCentury | Dec 22, 2016
Clinical News

Vemlidy regulatory update

Read More
BioCentury | Nov 17, 2016
Clinical News

Vemlidy regulatory update

Read More
BioCentury | Nov 11, 2016
Company News

CHMP recommendations include HBV drug Vemlidy

Read More
BioCentury | Nov 11, 2016
Clinical News

Vemlidy regulatory update

Read More
BioCentury | Nov 10, 2016
Company News

FDA approves Gilead's Vemlidy for HBV

Read More
BioCentury | Aug 1, 2016
Clinical News

Odefsey rilpivirine/emtricitabine/tenofovir alafenamide regulatory update

Read More
BioCentury | May 9, 2016
Clinical News

Odefsey rilpivirine/emtricitabine/tenofovir alafenamide regulatory update

Read More
BioCentury | May 2, 2016
Clinical News

Tenofovir alafenamide fumarate: Additional Phase III data

Read More
BioCentury | May 2, 2016
Clinical News

Tenofovir alafenamide fumarate: Additional Phase III data

Read More
Items per page:
1 - 10 of 43